Logo-apb
Research Article

1. Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy
Seyed-Ali Hosseinian* ORCID, Aliakbar Haddad-Mashadrizeh, Samaneh Dolatabadi
Adv Pharm Bull. 2018;8(3): 447-455. doi: 10.15171/apb.2018.052
PMCID: PMC6156485     PMID: 30276141     Scopus ID: 85052601466    
Article
PDF
XML
Cited By:
2
1
2
Research Article

2. Novel Methotrexate-Ciprofloxacin Loaded Alginate-Clay Based Nanocomposite as Anticancer and Antibacterial Co-Drug Delivery System
Mehrdad Mahkam ORCID, Fatemeh Bazmi Zeynabad, Effat Alizadeh, Mahdi Rahimi, Fariborz Rahimi* ORCID, Roya Salehi* ORCID
Adv Pharm Bull. 2021;11(3): 477-489. doi: 10.34172/apb.2021.055
PMCID: PMC8421626     PMID: 34513622     Scopus ID: 85108902176    
Article
PDF
Full Text
XML
Cited By:
3
2
13

Research Article

3. Co-Administration of Vadimezan and Recombinant Coagulase-NGR Inhibits Growth of Melanoma Tumor in Mice
Amir Daei Farshchi Adli, Rana Jahanban-Esfahlan, Khaled Seidi, Davoud Farajzadeh, Ramezan Behzadi, Nosratollah Zarghami* ORCID
Adv Pharm Bull. 2021;11(2): 385-392. doi: 10.34172/apb.2021.037
PMCID: PMC8046391     PMID: 33880362     Scopus ID: 85103213880    
Article
PDF
Full Text
XML
Cited By:
2
4
2
Research Article

4. Melanoma Cancer Therapy Using PEGylated Nanoparticles and Semiconductor Laser
Abdorreza Asrar ORCID, Zahra Sobhani ORCID, Mohammad Ali Behnam* ORCID
Adv Pharm Bull. 2022;12(3): 524-530. doi: 10.34172/apb.2022.055
PMCID: PMC9348541     PMID: 35935047     Scopus ID: 85140274726    
Article
PDF
Full Text
XML
Cited By:
0
1
7
Review Article

5. mRNA as a Therapeutics: Understanding mRNA Vaccines
Ferdi Oğuz ORCID, Harika Atmaca* ORCID
Adv Pharm Bull. 2022;12(2): 274-282. doi: 10.34172/apb.2022.028
PMCID: PMC9106950     PMID: 35620336     Scopus ID: 85128230280    
Article
PDF
Full Text
XML
Cited By:
0
1
1

Review Article

6. Biosynthesis of Quantum Dots and Their Therapeutic Applications in the Diagnosis and Treatment of Cancer and SARS-CoV-2
Musa Moetasam Zorab ORCID, Navid Mohammadjani, Morahem Ashengroph* ORCID, Mehran Alavi* ORCID
Adv Pharm Bull. 2023;13(3): 411-422. doi: 10.34172/apb.2023.065
PMCID: PMC10460808     PMID: 37646053    
Article
PDF
Full Text
XML
Cited By:
0
2
Review Article

7. Erythrocytes Nanoparticle Delivery: A Boon for Targeting Tumor
Adnan Rehmatullah Siddique* ORCID, Geeta Sameer Bhagwat ORCID
Adv Pharm Bull. 2024;14(1): 132-146. doi: 10.34172/apb.2023.080
PMCID: PMC10997934     PMID: 38585450    
Article
PDF
XML
Cited By:
0
Review Article

8. Targeted Hybrid Nanocarriers as Co-Delivery Systems for Enhanced Cancer Therapy
Joan Onyebuchi Erebor* ORCID, Elizabeth Oladoyin Agboluaje ORCID, Ava M. Perkins ORCID, Megha Krishnakumar, Ndidi Ngwuluka ORCID
Adv Pharm Bull. 2024;14(3): 558-573. doi: 10.34172/apb.2024.046
PMCID: PMC11530881     PMID: 39494247    
Article
PDF
XML
Cited By:
0
Review Article

9. Harnessing the Therapeutic Potential of Mesenchymal Stem Cells in Cancer Treatment

Parisa Kangari* ORCID, Reza Salahlou, Somayeh Vandghanooni* ORCID
Adv Pharm Bull. 2024;14(3): 574-590. doi: 10.34172/apb.2024.052
PMCID: PMC11530882     PMID: 39494266    
Article
PDF
XML
Cited By:
0

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by